No Prescription |
 |
 | ||
|
Aldomet (Methyldopa) |
|
| ||
No Prescription » Blood Pressure » Aldomet (Methyldopa) Aldomet (Methyldopa) lowers blood pressure by decreasing the levels of certain chemicals in your blood. This allows your blood vessels (veins and arteries) to relax (widen) and your heart to beat more slowly and easily. Aldomet (Methyldopa) is used to treat hypertension (high blood pressure). Buy Aldomet (Methyldopa) and other Blood Pressure products online at Medstore. Buy Online at Medstore - Click Here!
About Aldomet (Methyldopa): Product Type: Blood Pressure Brand name: Aldomet Generic name: Methyldopa What is Aldomet (Methyldopa)? Methyldopa lowers blood pressure by decreasing the levels of certain chemicals in your blood. This allows your blood vessels (veins and arteries) to relax (widen) and your heart to beat more slowly and easily. Methyldopa is used to treat hypertension (high blood pressure). Methyldopa may also be used for purposes other than those listed in this medication guide. What is the most important information I should know about Aldomet (methyldopa)? Do not stop taking methyldopa suddenly. This could cause severely high blood pressure nervousness and anxiety. Use caution when driving operating machinery or performing other hazardous activities. Methyldopa may cause dizziness or drowsiness. If you experience dizziness or drowsiness avoid these activities. Use caution when rising from a sitting or lying position especially first thing in the morning. You may become dizzy while taking methyldopa and you may fall and injure yourself if you get up quickly. What should I discuss with my healthcare provider before taking Aldomet (methyldopa)? You cannot take methyldopa if you have any type of liver disease. Do not take methyldopa if you are taking a monoamine oxidase inhibitor (MAOI) or if you have taken one in the last 14 days. MAOIs used to treat depression include isocarboxazid (Marplan) phenelzine (Nardil) and tranylcypromine (Parnate). Before taking this medication tell your doctor if you • have any type of heart disease • have had a heart attack or a stroke or • have kidney disease. You may need a lower dose or special monitoring during treatment with methyldopa if you have any of the conditions listed above. Methyldopa is in the FDA pregnancy category B. This means that it is not likely to harm an unborn baby. Do not take methyldopa without first talking to your doctor if you are pregnant. Methyldopa passes into breast milk. It is not known whether methyldopa will harm a nursing infant. Do not take this medication without first talking to your doctor if you are breast-feeding a baby. If you are over 60 years of age you may be more likely to experience side effects from methyldopa therapy. You may require a lower dose. How should I take Aldomet (methyldopa)? Take methyldopa exactly as directed by your doctor. If you do not understand these directions ask your pharmacist nurse or doctor to explain them to you. Take each dose with a full glass of water. Shake the suspension well before measuring a dose. To ensure that you get a correct dose measure the liquid form of methyldopa with a special dose-measuring spoon not with a regular tablespoon. If you do not have a dose-measuring device ask your pharmacist where you can get one. Do not stop taking this medication suddenly even if you feel better. You may need to take methyldopa for the rest of your life to control your condition. Store this medication at room temperature away from moisture and heat. What happens if I miss a dose? Take the missed dose as soon as you remember. However if it is almost time for your next dose skip the dose you missed and take only your next regularly scheduled dose. Do not take a double dose of this medication. What happens if I overdose? Seek emergency medical attention. Symptoms of a methyldopa overdose include drowsiness lethargy weakness lightheadedness a slow heart rate nausea vomiting and possibly seizures. What should I avoid while taking Aldomet (methyldopa)? Use caution when driving operating machinery or performing other hazardous activities. Methyldopa may cause dizziness or drowsiness. If you experience dizziness or drowsiness avoid these activities. Use caution when rising from a sitting or lying position especially first thing in the morning. You may become dizzy while taking methyldopa and you may fall and injure yourself if you get up quickly. Avoid alcohol while taking methyldopa. It may increase the drowsiness and may also increase dizziness. Use caution even with small amounts of alcohol. Aldomet (methyldopa) side effects If you experience any of the following serious side effects stop taking methyldopa and seek emergency medical attention: • an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips tongue or face; or hives); • a very slow heart rate (fewer than 60 beats per minute); • unusually high or low blood pressure (fainting a severe headache flushing of your face); • chest pain; • uncontrollable movements of your arms legs or facial muscles; • yellowing of your skin or eyes; or • unusual bleeding or bruising. Other less serious side effects may be more likely to occur. Continue to take methyldopa and talk to your doctor if you experience • unusual fatigue dizziness or tiredness; • headache; • constipation nausea vomiting or diarrhea; • insomnia; or • dry mouth (sucking on ice chips or sugarless hard candy may relieve this side effect). This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. What other drugs will affect Aldomet (methyldopa)? Do not take methyldopa if you are taking a monoamine oxidase inhibitor (MAOI) or if you have taken one in the last 14 days. MAOIs used to treat depression include isocarboxazid (Marplan) phenelzine (Nardil) and tranylcypromine (Parnate). Before taking methyldopa tell your doctor if you are taking any of the following medicines: • lithium (Eskalith Lithobid others); • haloperidol (Haldol); • levodopa (Dopar Larodopa Sinemet); • tolbutamide (Orinase); • a respiratory medicine such as albuterol (Ventolin Proventil Volmax others) pirbuterol (Maxair) or salmeterol (Serevent); • a beta-blocker such as carteolol (Cartrol) carvedilol (Coreg) labetalol (Trandate Normodyne) nadolol (Corgard) propranolol (Inderal) pindolol (Visken) or timolol (Blocadren); • a phenothiazine such as chlorpromazine (Thorazine) prochlorperazine (Compazine) perphenazine (Trilafon) fluphenazine (Prolixin) or thioridazine (Mellaril); • a barbiturate such as phenobarbital (Luminal Solfoton) pentobarbital (Nembutal) or secobarbital (Seconal); or • a tricyclic antidepressant such as amitriptyline (Elavil Endep) imipramine (Tofranil) doxepin (Sinequan) or nortriptyline (Pamelor). You may require special monitoring or a dose adjustment if you are taking any of the medicines listed above. Drugs other than those listed here may also interact with methyldopa or affect your condition. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines Generic Aldomet (Methyldopa) AMD Aldoclor Aldometil Aldomin Aldoril Alpha medopa Apo Methazide Baypresol Becanta Dopamet Dopatec Dopegyt Grospisk Hyperpax Hypolag Medomet Medopa Medopal Medopren Methoplain Novo-Doparil Novomedopa Nu-Medopa L-Methyl Dopa Pms-Dopazide Presinol Presolisin Sedometil Sembrina Supres 250mg 100 tabs 250mg 120 tabs 250mg 200 tabs 250mg 150 tabs 250mg 80 tabs Methyldopa Aldomet
View more Blood Pressure No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
